This educational program consists of three presentations on updates in anticoagulation management in AF and VTE.

This course consists of the following:

• Atrial fibrillation: From risk prediction to clinical outcomes - Prof. Stefan Hohnloser, MD – Frankfurt, Germany
• Optimizing oral anticoagulation management for patients with AF - Prof. Robert Storey, MD – Sheffield, UK
• Management of cancer-associated VTE - Prof. Stavros Konstantinides, MD – Mainz, Germany

How to obtain your CME certificate

• Watch the three lectures and answer the pre- and post-test questions
• Fill in the evaluation questions
• Download CME Certificate (if your score >70%)

After watching these three videos, the learner should be able to:

• Describe the most important updates in recent guidelines for the diagnosis and management of AF and of special patient populations with AF
• Interpret findings from studies on management of anticoagulation in patients with AF
• Recall outcomes of studies on anticoagulation in patients with cancer and VTE
• Describe the most important updates in recent guidelines on management of patients with cancer and VTE

Expert faculty

• Prof. Stefan Hohnloser, MD – Frankfurt, Germany
• Prof. Robert Storey, MD – Sheffield, UK
• Prof. Stavros Konstantinides, MD – Mainz, Germany

Target audience

This educational activity is designed for all healthcare professionals with an interest in management of patients with AF or VTE.

CME accreditation

This online course is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 hour of external CME credit.

Through an agreement between EBAC and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit™.

Funding

Funding for this educational program was provided by an unrestricted educational grant from Bristol-Myers Squibb/Pfizer.

Questions

For questions regarding this activity, please contact us at info@pace-cme.org.